Jonathan Havel, Ph.D.

Jonathan is a purpose-driven researcher with experience in tumor immunology, cancer cell signaling and high-throughput assay design. Prior to joining Volastra, he was a postdoctoral fellow at the Memorial Sloan Kettering Cancer Center, where he studied novel determinants of cancer immunotherapy response. He graduated from Lehigh University with a bachelor’s degree in biochemistry and earned a Ph.D. in molecular pharmacology from Emory University.